Topic: How To Invest

Wall Street Stock Forecaster Hotline – Friday, December 16, 2022

Article Excerpt

PFIZER INC., $51.43, New York symbol PFE, is your #1 Income Buy for 2022. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Eliquis (stroke), Ibrance (breast cancer) and Prevnar (pneumonia). Pfizer has increased its dividend rate each year since 2011. Starting with the March 2022 payment, the company raised your quarterly dividend by 2.6%. Investors now receive $0.40 a share instead of $0.39. The new annual rate of $1.60 yields a solid 3.1%. Pfizer has now received approval to sell its Paxlovid COVID-19 treatment in China. Demand for the drug should be strong as China relaxes its lockdown policies and COVID-19 cases rise. The company also announced a new plan to replace $17 billion in annual sales from drugs that will lose their patent protection by 2030. The plan includes developing new vaccines that use the same messenger RNA technology behind its Comirnaty COVID-19 vaccine for both influenza and diseases. Pfizer expects annual sales of those new products…